Quattam Biopharma Announces Strong Q2 Results – Asset Growth, Converting All Debt to Equity, Continued Going Concern Exclusion, Stock Price Triples, Crypto Assets Increase by Over $500,000, Debt Nearly Cleared
Quattam Biopharma demonstrated a strong second quarter, with current and total assets increasing, and its stock price...